公开(公告)号：US20140142316A1

公开(公告)日：2014-05-22

申请号：US13863534

申请日：2013-04-16

Applicant: Pfizer Inc.

Inventor： Hengmiao CHENG ,  Xiao HU ,  Kevin D. JEROME ,  Mark G. OBUKOWICZ ,  Lisa Maria OLSON ,  Paul V. RUCKER ,  Ronald Keith WEBBER

IPC: C07D213/89

CPC classification number: C07D213/89 ,  A61K31/44 ,  C07D213/72 ,  C07F9/58 ,  Y10S514/886

Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

Abstract translation: 本发明涉及式I化合物或其盐，它们是糖皮质激素受体的调节剂。 本发明的化合物和盐可用于治疗由糖皮质激素受体活性介导的病症。